Biotage AB (publ) (STO:BIOT)
Sweden flag Sweden · Delayed Price · Currency is SEK
141.70
+0.30 (0.21%)
May 9, 2025, 3:00 PM CET

Biotage AB Revenue

Biotage AB had revenue of 385.00M SEK in the quarter ending March 31, 2025, a decrease of -19.79%. This brings the company's revenue in the last twelve months to 1.96B, down -1.01% year-over-year. In the year 2024, Biotage AB had annual revenue of 2.06B with 10.42% growth.

Revenue (ttm)
1.96B
Revenue Growth
-1.01%
P/S Ratio
5.77
Revenue / Employee
3.15M
Employees
680
Market Cap
11.32B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20242.06B194.00M10.42%
Dec 31, 20231.86B296.00M18.90%
Dec 31, 20221.57B334.00M27.11%
Dec 31, 20211.23B140.00M12.82%
Dec 31, 20201.09B-9.37M-0.85%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Swedish Orphan Biovitrum AB 26.24B
Sectra AB 3.30B
Getinge AB 35.57B
Camurus AB 1.87B
Medicover AB 23.56B
AddLife AB 10.42B
Vitrolife AB 3.61B
Vimian Group AB 4.24B
Revenue Rankings